TY - JOUR
T1 - Pulmonary vein ablation for atrial fibrillation
T2 - When should this be the treatment of choice?
AU - Pappone, Carlo
AU - Rosanio, Salvatore
PY - 2003
Y1 - 2003
N2 - At the present time, there is no universal consensus on which AF patients should undergo catheter ablation as a first-line approach. However, the presence of structural heart diseases, the LA size, the type of AF, comorbidities and the need for long-term anticoagulant and antiarrhythmic therapy may determine the type and role of the PV ablation strategy. To develop PV ablation as a mainstream therapy for AF will require controlled, randomized studies in specific subgroups of the AF population.
AB - At the present time, there is no universal consensus on which AF patients should undergo catheter ablation as a first-line approach. However, the presence of structural heart diseases, the LA size, the type of AF, comorbidities and the need for long-term anticoagulant and antiarrhythmic therapy may determine the type and role of the PV ablation strategy. To develop PV ablation as a mainstream therapy for AF will require controlled, randomized studies in specific subgroups of the AF population.
UR - http://www.scopus.com/inward/record.url?scp=0037221982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037221982&partnerID=8YFLogxK
U2 - 10.1016/S1062-1458(02)01085-1
DO - 10.1016/S1062-1458(02)01085-1
M3 - Article
AN - SCOPUS:0037221982
VL - 12
SP - 75
EP - 78
JO - ACC Current Journal Review
JF - ACC Current Journal Review
SN - 1062-1458
IS - 1
ER -